Gregory Balani, PharmD

Researcher
DISC Type : Cs

Vice President, Business Development at Mendra

New York, New York, United States

Overview

Gregory Balani is a seasoned pharmaceutical business development executive, currently serving as VP at Mendra. A Doctor of Pharmacy from UCSF, he has a strong track record in corporate strategy, playing key roles in the acquisitions of Escient Pharmaceuticals by Incyte for $750M and Zogenix by UCB for $1. 9B.

His academic work includes publications on the cost-effectiveness of cancer treatments and ethical issues in microfinance, demonstrating a deep interest in the intersection of healthcare economics and social impact. He earned his Bachelor of Science from DePaul University.

Unique fact: He has been instrumental in two major pharmaceutical company acquisitions with a combined value of over $2. 6 billion.

Personality Overview

Cost Conscious

Self-Disciplined

Detail Oriented

Being observant comes to them naturally.  They are always well-planned and adopt a systematic approach. The only way to convince them is by showing them examples and ample proof.

Topics They Care About

Pharma M&A
He played a key role in two major acquisitions: Zogenix by UCB for $1. 9B and Escient Pharmaceuticals by Incyte for $750M, showcasing his expertise in high-value corporate transactions.
Rare Disease Therapies
His current role at Mendra and previous experience at Zogenix, which focused on rare disease therapies, highlight this as a core professional passion.
CNS Disorders
Expressed excitement for supporting companies tackling central nervous system disorders like schizophrenia and Alzheimer’s disease, indicating a specific interest in this therapeutic area.

Media Appearances

Gregory has no verified media appearances

Work History

10-2025
Vice President, Business Development at Mendra
10-2024 - 10-2025
Sr. Associate at Avego
8-2024 - 10-2024
VC Consultant / IIR at Ally Bridge Group
8-2022 - 7-2024
Senior Director, Head of Business Development at Escient Pharmaceuticals
4-2021 - 7-2022
Director, Business Development at Zogenix, Inc.

Education

Doctor of Pharmacy (Pharm.D.) from University of California, San Francisco
Bachelor of Science (BS) from DePaul University

More Information

Social Presence :

Prographics :

Exp : 7 Location : New York, New York, United States Job Level : Senior Designation : Vice President, Business Development at Mendra
URL has been copied!

Insights For Selling To Gregory

During A Call Or A Meeting

DO's

  • Use a presentation with information before getting into a live product walkthrough
  • Share a one-off customer success story but keeps the focus on highlighting objective, numerical results
  • If they are not asking many questions, nudge them to ask questions rather than just starting to talk yourself

DONT's

  • Avoid winging it with them particularly, answer a question only if you know the answer well
  • Don't ask them to move fast, let them take their time and digest all the information
  • Do not sound overly eager, modulate your energy levels especially if you are generally enthusiastic

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Gregory is

  • For them, low risk and acceptance by others are very important, followed by proof of ROI.
  • Will you ever get a clear answer from Gregory

  • Often, they don't say no, or keep going about it in circles.

Insights For Deal Planning

    How fast (or slow) will Gregory move?

  • They do not like to take decisions in a hurry, so they could be slow in making their mind up.
  • Can Gregory take some risk or not?

  • They are low on risk-appetite and prefer to make informed decisions.

You And Gregory

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.